<DOC>
	<DOC>NCT02300506</DOC>
	<brief_summary>The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).</brief_summary>
	<brief_title>Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>Inclusion criteria: Malignant Glioma, patients enrolled in study GLI01S. Exclusion criteria: Corresponding to contraindication of Gliadel. Not applicable to indications of Gliadel.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Malignant Glioma</keyword>
	<keyword>Glioblastoma multiforme</keyword>
</DOC>